
|Articles|February 1, 2005
Adherence to glaucoma therapy of vital importance
New Orleans—Patient adherence to prostaglandin analogue or prostamide therapy for glaucoma is high but not perfect. There are still opportunities to improve adherence to therapy with these drugs, according to Jacob Wilensky, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Advancements in laser refractive surgery
2
From then to next: Five decades of transformation in ophthalmology
3
Optigo: Lead anti-VEGF program advancing toward IND-enabling studies
4
Q&A: Advancing a long-acting anti-VEGF candidate: What it means for retinal disease
5


















































.png)


